179 related articles for article (PubMed ID: 16713453)
1. Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis.
Shen Z; Chen L; Liu YF; Gao TW; Wang G; Fan XL; Fan JY; Fan PS; Li CY; Liu B; Dang YP; Li CX
J Am Acad Dermatol; 2006 Jun; 54(6):992-1002. PubMed ID: 16713453
[TBL] [Abstract][Full Text] [Related]
2. HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.
Shen Z; Wang G; Fan JY; Li W; Liu YF
J Dermatol Sci; 2005 Apr; 38(1):25-39. PubMed ID: 15795121
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
[TBL] [Abstract][Full Text] [Related]
4. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin?
Valdimarsson H; Sigmundsdóttir H; Jónsdóttir I
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():21-4. PubMed ID: 9020931
[TBL] [Abstract][Full Text] [Related]
5. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841
[TBL] [Abstract][Full Text] [Related]
6. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products.
Prinz JC; Gross B; Vollmer S; Trommler P; Strobel I; Meurer M; Plewig G
Eur J Immunol; 1994 Mar; 24(3):593-8. PubMed ID: 8125129
[TBL] [Abstract][Full Text] [Related]
7. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
8. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.
Skov L; Chan LS; Fox DA; Larsen JK; Voorhees JJ; Cooper KD; Baadsgaard O
Am J Pathol; 1997 Feb; 150(2):675-83. PubMed ID: 9033280
[TBL] [Abstract][Full Text] [Related]
9. Keratin 17 as a therapeutic target for the treatment of psoriasis.
Fu M; Wang G
J Dermatol Sci; 2012 Sep; 67(3):161-5. PubMed ID: 22795618
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder.
Zhang K; Li X; Yin G; Liu Y; Niu X; Hou R
Br J Dermatol; 2008 Feb; 158(2):298-305. PubMed ID: 18070209
[TBL] [Abstract][Full Text] [Related]
11. Influence of psoriatic peripheral blood CD4+ T and CD8+ T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes.
Li X; Fan X; Zhang K; Yin G; Liu Y
Eur J Dermatol; 2007; 17(5):392-6. PubMed ID: 17673382
[TBL] [Abstract][Full Text] [Related]
12. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
Li R; Li X; Li Z
Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
[TBL] [Abstract][Full Text] [Related]
13. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of psoriasis.
Kadunce DP; Krueger GG
Dermatol Clin; 1995 Oct; 13(4):723-37. PubMed ID: 8785878
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
Dayan M; Sthoeger Z; Neiman A; Abarbanel J; Sela M; Mozes E
Hum Immunol; 2004 Jun; 65(6):571-7. PubMed ID: 15219376
[TBL] [Abstract][Full Text] [Related]
16. The PSORS1 locus gene CCHCR1 affects keratinocyte proliferation in transgenic mice.
Tiala I; Wakkinen J; Suomela S; Puolakkainen P; Tammi R; Forsberg S; Rollman O; Kainu K; Rozell B; Kere J; Saarialho-Kere U; Elomaa O
Hum Mol Genet; 2008 Apr; 17(7):1043-51. PubMed ID: 18174193
[TBL] [Abstract][Full Text] [Related]
17. Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy.
Kinnunen T; Jutila K; Kwok WW; Rytkönen-Nissinen M; Immonen A; Saarelainen S; Närvänen A; Taivainen A; Virtanen T
J Allergy Clin Immunol; 2007 Apr; 119(4):965-72. PubMed ID: 17335888
[TBL] [Abstract][Full Text] [Related]
18. Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
Gruener NH; Gerlach TJ; Ulsenheimer A; Diepolder HM; Wierenga E; Zachoval R; Heeg M; Pape GR; Jung MC
Vaccine; 2007 Jun; 25(26):4960-6. PubMed ID: 17466417
[TBL] [Abstract][Full Text] [Related]
19. Investigation of mitomycin-C-treated fibroblasts in 3-D collagen gel and conditioned medium for keratinocyte proliferation.
Huang YC; Wang TW; Sun JS; Lin FH
Artif Organs; 2006 Mar; 30(3):150-9. PubMed ID: 16480389
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cell death and proliferation in psoriatic epidermis.
Kawashima K; Doi H; Ito Y; Shibata MA; Yoshinaka R; Otsuki Y
J Dermatol Sci; 2004 Sep; 35(3):207-14. PubMed ID: 15381242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
